🧠 Medtech on the Brain 🧠 Vijay Ravindran, founder of autism therapy digital therapeutic firm Floreo, spoke to Medtech Insight about working with the FDA and why the TAP pilot made sense for them: https://ow.ly/nnZV50TgzO1. Medtech Insight is raising awareness for mental health, Alzheimer’s and brain health by speaking with industry leaders about emerging innovations to address neurological diseases and mental health, the regulatory and investment climate, reimbursement, and more. Check out the entire series here: https://ow.ly/eKh450TgzO2.
Citeline Commercial’s Post
More Relevant Posts
-
Today marks the start of the Alzheimer Europe Conference in Geneva. Over the next few days there will be many clinical insights and research highlights discussed. We are ready and set-up at booth number 5. #34AEC #AlzheimersDisease #AlzheimersAwareness
-
-
Is Early Diagnosis Ethical? Artificial Intelligence offers significant benefits in efficiency and time-saving, particularly in the medical field. However, with every advancement comes new ethical challenges. Explore our insights on this topic! Spoiler alert: The human element remains crucial, especially when it comes to explaining results and providing personalized care.
Thrilled to share insights on an innovative approach to healthcare! We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by College of Optometrists. Prof. Alastair Denniston says, "The power of oculomics is that we can look into your eye and see signals of your present and future health." "We like to think we’re the optometrist's best friend, as RetinaLyze will support decision-making and, in many cases, identify early signs of eye disease before the human eye can," says Chris Flynn, RetinaLyze’s UK Lead. Click below for reading or free download of the full article! And do join the conversation and let's explore how these technologies are shaping our understanding of health diagnostics: Want to know how RetinaLyze can benefit your practice? Get in touch or sign up for a free trial! Let's embrace the future of healthcare together! #HealthTech #AI #Ophthalmology #RetinaLyze #Oculomics
-
Society for Clinical Research Sites (SCRS) Alzheimer's roundtable session. Sean Stanton and Steve Satek sharing insight into transforming your site to manage this patient population, along the strategic decisions needed to become selected for such studies. Great discussion to be part of today! #FutureMedicalResearch #SCRS #AlzheimersDisease #InnovativeHealthcare
-
-
Geriatric and Brain Intervention Psychiatrist, Endowed Research Chair at Ontario Shores Centre for Mental Health Sciences
Preprint of our paper commissioned by the Canadian Consortium on Neurodegeneration in Aging and led by Eric Smith and colleagues on the opportunities, challenges, and future research related to the use of anti-amyloid therapies for early Alzheimer in the Canadian Health Care context. The paper is under peer review for final version!
-
Thrilled to share insights on an innovative approach to healthcare! We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by College of Optometrists. Prof. Alastair Denniston says, "The power of oculomics is that we can look into your eye and see signals of your present and future health." "We like to think we’re the optometrist's best friend, as RetinaLyze will support decision-making and, in many cases, identify early signs of eye disease before the human eye can," says Chris Flynn, RetinaLyze’s UK Lead. Click below for reading or free download of the full article! And do join the conversation and let's explore how these technologies are shaping our understanding of health diagnostics: Want to know how RetinaLyze can benefit your practice? Get in touch or sign up for a free trial! Let's embrace the future of healthcare together! #HealthTech #AI #Ophthalmology #RetinaLyze #Oculomics
-
💡 How do we fight Alzheimer's more effectively? By ensuring that the right data reaches the right people at the right time. The collaboration between Global Research Platforms and Zühlke is enabling just that—helping researchers access and analyse crucial data faster. By combining cutting-edge technology with deep expertise, we’re making a meaningful impact in the search for better treatments and, ultimately, a cure.
-
Healthcare Informatics Specialist | Data Analysis & Visualizations | Clinical Research | Attention to Detail
📢 Exciting News! I am thrilled to announce that my research titled "The Prevalence of Alzheimer's Disease and Hospital Readmission Rates: A Retrospective Study" has been published on Research Square as a preprint and is now a citable part of the scholarly record! ✍ This comprehensive study explores the relationship between Alzheimer's disease and hospital readmission rates, highlighting the healthcare burden associated with this condition. I hope it provides valuable insights and promotes ongoing discussions about healthcare solutions and policymaking for Alzheimer's care. You can read the full preprint here: 🔗 https://lnkd.in/gAkRc8Mw 🔗 Additionally, the study has been published on Prime Scholars (2025) under the same title: "The Prevalence of Alzheimer’s Disease and Hospital Readmission Rates: A Retrospective Study." URL: https://lnkd.in/dPEuUewy 💐 I would like to extend my gratitude to Dr. Ingrid Vasiliu-Feltes for her critical review and assistance in finalizing the manuscript. I welcome any feedback and discussions on this important topic! #AlzheimersDisease #RetrospectiveStudy #HospitalReadmissions #HealthcareResearch #DataAnalysis #DataVisualizations
-
The PINC AI™ Brain and Memory Collaborative (BMC) is a national learning collaborative focused on creating smarter, standardized approaches for multi-stakeholders to collaborate and improve the patient journey and health outcomes for patients with Alzheimer’s disease or Parkinson’s disease. Watch below to hear about some of the benefits of joining the BCM from Kari Kalgren, Executive Director of Strategy and Innovation, and click here to learn more: https://lnkd.in/gH8QcEdi
-
Interested in new frontiers in respiratory clinical trials? 👇 Check out our free on-demand webinar! In this video, Clario's new SVP and Chief AI Officer, Marko Topalovic; Director of Scientific Affairs, Kevin McCarthy; and Senior Director of Respiratory Solutions, Philip Lake, Ph. D., discuss: - Cutting-edge AI-driven approaches to spirometry data analysis, revolutionizing at-home testing with instant feedback and heightened efficacy. - Virtual integration of clinicians into participants' homes, ensuring top-notch data quality and engaging participant experiences. - Remote monitoring of lung sounds and their significant impact on respiratory endpoints within clinical trials. - Explore alternative respiratory endpoints that surpass traditional spirometry, providing greater flexibility and a more comprehensive assessment of lung health. ▶️ Watch now and stay ahead in respiratory research! https://hubs.li/Q02FPVsC0 #spirometry #respiratorycare #clinicaltrials #artificialintelligence
-
-
Big news for Alzheimer's diagnosis and treatment! 🧠 In a recent Q&A with G2 Intelligence managing editor Rachel (Muenz) Vachon, Dr. Andreas Jeromin discusses how close Alzheimer's blood tests are to full regulatory approval. Used appropriately, these tests could make early detection more accessible and less invasive, bringing hope to millions. Understanding Alzheimer's is crucial, and these tests represent a significant advance in our ability to manage this disease. Early detection means better chances for effective management and treatment. Let's keep the conversation going! Read more about this exciting development and share your thoughts. What does this mean for you and your patients? 👉 Read the full article here: https://lnkd.in/e3Stzffn #AlzheimersResearch #HealthInnovation #MedicalScience
-
